NCT04435353

Assessment of the Effectiveness of Vibroacoustic Therapy for Respiratory Failure Caused by COVID 19

• Status: Unknown
• Phase: N/A
• Study type: Interventional
• Enrollment: 200 (estimated)
• Sponsor: Astana Medical University · Academic / Other
• Sex: All
• Age: 18 Years – 75 Years
• Healthy volunteers: Not accepted

Summary

Vibroacoustic pulmonary therapy in patients with COVID19 is believed to have a positive effect on oxygen status and a decrease in the duration of respiratory failure

Detailed description

This study aims to recruit the required number of patients for statistical identification of the effectiveness of vibroacoustic therapy in patients with COVID 19. Obligatory performance criteria will be presented by the duration of the course of respiratory failure and the duration of mechanical ventilation in the main and control groups. Optional performance criteria will be represented by oximetry values and standardization of laboratory parameters

Conditions

• Respiratory Distress Syndrome
• Hypoxemia

Interventions

Type	Name	Description
DEVICE	VibroLUNG	Lungs intensive therapy

Timeline

• Start date: 2020-03-22
• Primary completion: 2020-12-31
• Completion: 2021-02-01
• First posted: 2020-06-17
• Last updated: 2020-06-17

Locations

2 sites across 1 country: Kazakhstan